Table 1 A list .... (as shown in text).

From: Statistical challenges in haematopoietic cell transplantation

1. Fraser R. Inappropriate use of statistical power. (in press).

2. De Wreede LC, Scheteling J, Putter H. Analysis of survival outcomes in haematopoietic cell transplant studies: pitfalls and solutions. (in press).

3. Othus M, Zhang MJ, Gale RP. Clinical trials: design, endpoints and interpretation of outcomes. Bone Marrow Transplant. 2022;7:1–5.

4. Cai J, Kim S. Case-cohort design in hematopoietic cell transplant studies. Bone Marrow Transplant. 2021;16:1–5.

5. Hu ZH, Wang HL, Gale RP, Zhang MJ. A SAS macro for estimating direct adjusted survival functions for time-to-event data with or without left truncation. Bone Marrow Transplant. 2021;19:1–5.

6. Moodie EE, Krakow EF. Precision medicine: Statistical methods for estimating adaptive treatment strategies. Bone Marrow Transplant. 2020;55:1890–6.

7. Othus M, Gale RP, Hourigan CS, Walter RB. Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantation. Bone Marrow Transplant. 2020;55:843–50.

8. Gauthier J, Wu QV, Gooley TA. Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians. Bone Marrow Transplant. 2020;55:675–80.

9. Hu ZH, Gale RP, Zhang MJ. Direct adjusted survival and cumulative incidence curves for observational studies. Bone Marrow Transplant. 2020;55:538–43.

10. Zheng C, Dai R, Gale RP, Zhang MJ. Causal inference in randomized clinical trials. Bone Marrow Transplant. 2020;55:4–8.

11. Gale RP, Zhang MJ. Statistical analyses of clinical trials in haematopoietic cell transplantation or why there is a strong correlation between people drowning after falling out of a fishing boat and marriage rate in Kentucky. Bone Marrow Transplant. 2020;55:1–3.